Harmful and potential abuse of quetiapine. Case report and review of the evidence

Authors

  • Erik García Muñoz ESE Hospital Carisma

DOI:

https://doi.org/10.21501/24631779.2637

Keywords:

Abuse, Addiction, Cocaine, Quetiapine

Abstract

Quetiapine is a second generation antipsychotic that is widely used in treating several psychiatric illnesses, including those related to substance abuse. Regardless of its efficiency and approved use, there are several reports on its potential abuse.
In this article there is the first case in Hispanic America, there is likewise a literature review that references the case reports, epidemiological studies and animal model studies. The risky use or search pattern-the compulsive use of quetiapine is reported in vulnerable individuals with a history of disorders due to substance use, usually related to cocaine. There is a
discussion regarding this phenomenon. Regardless of the fact that evidence on this phenomenon comes from preclinical studies, not necessarily from better sources, the case reports should be taken into account in patient assessment regarding how useful this drug is and the possible risks in treating patients with substance consumption related disorders.

Downloads

Download data is not yet available.

References

Brutcher, R. E., Nader, S. H., & Nader, M. A. (2016). Dependence potential of quetiapine: behavioral pharmacology in rodents. The journal of pharmacology and experimental therapeutics, 21(4), 307-312.

Cha, H. J., Lee, H.-A., Ahn, J.-I., Jeon, S.-H., Kim, E. J., & Jeong, H.-S. (2013). Dependence potential of quetiapine: behavioral pharmacology in rodents. Biomolecules and Therapeutics, 21(4), 307–312. https://doi.org/10.4062/biomolther.2013.035

Chen, C.-Y., Shiah, I.-S., Lee, W.-K., Kuo, S.-C., Huang, C.-C., & Wang, T.-Y. (2009). Dependence on quetiapine in combination with zolpidem and clonazepam in bipolar depression. Psychiatry and clinical neurosciences, 63, 427–8. https://doi.org/10.1111/j.1440-1819.2009.01953.x

Cornelis, C., Van Gastel, A., Dumont, G., Coppens, V., Sabbe, B., Morrens, M., & Van Den Eede, F. (2016). A case of dose escalation of quetiapine in persistent insomnia disorder. Acta Clinica Belgica, 3286, 1–3.

Croissant, B., Klein, O., Gehrlein, L., Kniest, A., Hermann, D., Diehl, A., & Mann, K. (2006). Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms : a case series, 21, 570–573.

Dando, T., & Keating, G. (2005). Quetiapine. A review of its use in acute mania and depression associated with bipolar disorder. Drugs, 65, 2533–2551. https://doi.org/10.2165/00003495-200565170-00008

Fischer, B. a, & Boggs, D. L. (2010). The role of antihistaminic effects in the misuse of quetiapine: a case report and review of the literature. Neuroscience and biobehavioral reviews, 34, 555–8. https://doi.org/10.1016/j.neubiorev.2009.11.003

Gallo, A., Lapointe, S., Stip, E., Potvin, S., & Rompré, P. P. (2010). Quetiapine blocks cocaine-induced enhancement of brain stimulation reward. Behavioural Brain Research, 208, 163–168. https://doi.org/10.1016/j.bbr.2009.11.029

Garrison, K. A., Zeffiro, T. A., Scheinost, D., Constable, R. T., & Brewer, J. A. (2015). Meditation leads to reduced default mode network activity beyond an active task. Cognitive, affective & behavioral neuroscience, 15, 712–720. https://doi.org/10.3758/s13415-015-0358-3

Haridas, A., Kushon, D., & Gurmu, S. (2015). Smoking quetiapine: a “Maq Ball”? Primary Psychiatry, 17, 38–39.

Hussain, M. (2005). Intravenous quetiapine abuse. American Journal of Psychiatry, 162, 1755–1756.

https://doi.org/10.1176/appi.ajp.162.9.1755-a

Kalivas, P. W., & Volkow, N. D. (2005). The neural basis of addiciton: a pathology of motivation and choice. Am J Psychiatry, 162, 1403–1413. https://doi.org/10.1176/appi.ajp.162.8.1403

Klein-Schwartz, W., Schwartz, E. K., & Anderson, B. D. (2014). Evaluation of quetiapine abuse and misuse reported to poison centers. Journal of Addiction Medicine, 8, 195–198. https://doi.org/10.1097/ADM.0000000000000020

Kolli, P. V., & Mary, H. (2016). Quetiapine addiction in an adolescent, 26, 174–176.

Koob, G. F. (2013). Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. Current Topics of Behavioral Neurosciences, 13, 3–30. https://doi.org/10.1007/978-3-642-28720-6_129

Koob, G. F. (2015). The dark side of emotion: The addiction perspective. European Journal of Pharmacology, 753, 73–87. https://doi.org/10.1016/j.ejphar.2014.11.044

Koob, G. F., & Volkow, N. D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 35, 217–38. https://doi.org/10.1038/npp.2009.110

Lerman, C., Gu, H., Loughead, J., Ruparel, K., Yang, Y., & Stein, E. a. (2014). Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function. JAMA Psychiatry, 71, 523. https://doi.org/10.1001/jamapsychiatry.2013.4091

Liang, X., He, Y., Salmeron, B. J., Gu, H., Stein, E. A., & Yang, Y. (2015). Interactions between the salience and default-mode networks are disrupted in cocaine addiction. J Neurosci, 35, 8081–8090. https://doi.org/10.1523/JNEUROSCI.3188-14.2015

Malekshahi, T. D. M., Tioleco, N. D. M., Ahmed, N., Campbell, A. N. C., … Ph, D. (2015). Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse. Journal of Substance Abuse Treatment, 48, 8–12. https://doi.org/10.1016/j.jsat.2014.07.006

Mattson, M. E., Albright, V. A., Yoon, J., & Council, C. L. (2015). Emergency Department Visits Involving Misuse and Abuse of the Antipsychotic Quetiapine. Results from the drug abuse warning network ( DAWN ), 39–46.

McFadden, K. L., Cornier, M., Melanson, E. L., Bechtell, J. L., & Tregellas, J. R. (2013). Effects of exercise on resting-state default mode and salience network activity in overweight/obese adults. Neuroreport, 24, 866–71. https://doi.org/10.1097/WNR.0000000000000013

McLarnon, M. E., Fulton, H. G., Maclsaac, C., & Barrett, S. P. (2012). Characteristics of quetiapine misuse among clients of a community-based methadone maintenance program. Journal of Clinical Psychopharmacology, 32, 721–723. https://doi.org/10.1097/JCP.0b013e3182670648

Morin, A. K. (2007). Possible intranasal quetiapine misuse. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 64, 723–725. https://doi.org/10.2146/ajhp060226

Murphy, D., Bailey, K., Stone, M., & Wirshing, W. C. (2008). Addictive potential of quetiapine. The American journal of psychiatry, 165, 918. https://doi.org/10.1176/appi.ajp.2008.08020277

Paparrigopoulos, T., Karaiskos, D., & Liappas, J. (2008). Quetiapine: Another drug with potential for misuse? A case report. Journal of Clinical Psychiatry. https://doi.org/10.4088/JCP.v69n0122a

Pierre, J. M., Shnayder, I., Wirshing, D. a, & Wirshing, W. C. (2004). Intranasal quetiapine abuse. The american journal of psychiatry, 161, 1718. https://doi.org/10.1176/appi.ajp.161.9.1718

Pinta, E. R., & Taylor, R. E. (2007). Quetiapine addiction? American Journal of Psychiatry, 164, 174–175. https://doi.org/10.1176/ajp.2007.164.1.174

Reeves, R., & Brister, J. (2007). Additional evidence of the abuse potential of quetiapine. Souther Medical Journal, 100, 834–836. https://doi.org/10.1097/SMJ.0b013e3180f62d53

Rensburg, J. V., Taylor, A., Hodgson, T. & Benattayallah, A. (2009). Acute exercise modulates cigarette cravings and brain activation in response to smoking-related images : an fMRI study. Psychopharmacology, 203, 589–598. https://doi.org/10.1007/s00213-008-1405-3

Sansone, R. a, & Sansone, L. a. (2010). Is seroquel developing an illicit reputation for misuse/abuse? Psychiatry (Edgmont (Pa. : Township)), 7, 13–6.

Sinha, R., Fuse, T., Aubin, L. R., & O’Malley, S. S. (2000). Psychological stress, drug-related cues and cocaine craving. Psychopharmacology, 152, 140–148. https://doi.org/10.1007/s002130000499

Tarasoff, G., & Osti, K. (2007). Black-market value of antipsychotics, antidepressants, and hypnotics in Las Vegas, Nevada. The american journal of psychiatry, 164, 350 https://doi.org/10.1176/ajp.2007.164.2.350

Tomasi, D., & Volkow, N. D. (2013). Striatocortical pathway dysfunction in addiction and obesity: differences and similarities. Critical reviews in biochemistry and molecular biology, 48, 1–19. https://doi.org/10.3109/10409238.2012.735642

Volkow, N. D., & Baler, R. D. (2015). NOW vs LATER brain circuits: Implications for obesity and addiction. Trends in Neurosciences, 38, 345–352. https://doi.org/10.1016/j.tins.2015.04.002

Volkow, N. D., Wang, G., Fowler, J. S., Tomasi, D., & Baler, R. (2011). Addiction: Decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain’s control circuit. BioEssays, 32, 748–755. https://doi.org/10.1002/bies.201000042

Volkow, N. D., Wang, G. J., Tomasi, D., & Baler, R. D. (2013). Unbalanced neuronal circuits in addiction. Current Opinion in Neurobiology, 23, 639–648. https://doi.org/10.1016/j.conb.2013.01.002

Volkow, N. D., Wang, G., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F., … Swanson, J. M. (2009). Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA, 302, 1084–91. https://doi.org/10.1001/jama.2009.1308

Waters, B., & Joshi, K. (2007). Intravenous Quetiapine-Cocaine Use (“Q-Ball”). American Journal of Psychiatry, 164, 173–174. https://doi.org/10.1176/ajp.2007.164.1.173a

Whitfield-Gabrieli, S., & Ford, J. M. (2012). Default mode network activity and connectivity in psychopathology. Annual Review of Clinical Psychology, 8, 49–76. https://doi.org/10.1146/annurev-clinpsy-032511-143049

Yargic, I., & Caferov, C. (2011). Quetiapine dependence and withdrawal: a case report. Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse, 32, 168–9. https://doi.org/10.1080/08897077.2011.558448

Yatham, L., Kennedy, S., & Schaffer, A. (2009). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders, 11, 225–255. https://doi.org/10.1111/j.1399-5618.2009.00672.x

Downloads

Published

2018-01-02

How to Cite

García Muñoz, E. (2018). Harmful and potential abuse of quetiapine. Case report and review of the evidence. Drugs and Addictive Behavior, 3(1), 93–108. https://doi.org/10.21501/24631779.2637

Issue

Vol. 3 No. 1 (2018)

Section

Estudio de Caso

License

INTELLECTUAL PROPERTY

The authors are morally and legally responsible for the content of their articles, as well as respect for copyright. Therefore, these do not compromise in any way the Luis Amigó University Foundation.

The reproduction of the articles will be governed as described in http://creativecommons.org/

PUBLICATIONS POLICY

• The author must send the statement of assignment of economic rights and the declaration of conflicts of interest in favor of the journal. Said document will be provided by the Editor and indicates the originality of the article, which is not published and which is not simultaneously postulated in another medium.

• The address of the journal Drugs and Addictive Behavior will confirm to the author, in a maximum of three (3) days, the reception of the received contribution, if its sending is done through the electronic mail; or immediately, if it is entered through the OJS (Open Journal Systems). The reception of articles does not imply an obligation to publish them.

• The journal Drugs and Addictive Behavior will submit the articles received for initial evaluation by the Editorial Committee; In case the Committee finds the material relevant, it will be evaluated by anonymous arbitrators, who will determine if it is publishable.

• Once the evaluation of the article has begun, the authors agree not to remove it in any part of the process.

• Printed items will not be received. All the proponents will have to send their writings through the e-mail of the magazine or the OJS.

• Partial versions of the text will not be received, that is, those that the author considers to modify and that are not structurally adjusted to a type of article.

• Once the article is sent, it is understood that the author authorizes the publication of their contact information and institutional affiliation.

• The authors are directly responsible for the ideas, judgments and opinions expressed in the articles; in such a way that the content does not compromise the thinking of the Editorial Committee or the Institution.

ETHICS OF PUBLICATION

• The Editorial Committee, by virtue of transparency in the processes, will ensure the academic quality of the journal.

• Causes of rejection are considered: plagiarism and self-plagiarism, adulteration, invention or falsification of content and author data, and that the article is not original and unpublished.

• The editor will verify the relevance of the article, in accordance with the policies of the journal and supported by Turnitin's Originality Check, software that detects errors in the handling of appointments, possible copies and plagiarism. If it considers it viable, it will send the article to the arbitrators; otherwise it will report the findings to the author and discard it. The articles must have a minimum originality level of 75%.

• In no case, the journal's management will require the author to cite it or publish articles with conflicts of interest.

• If once the article is published: 1) the publisher discovers plagiarism, adulteration, invention or falsification of data of the content and the author or substantive errors that attempt against the quality or scientificity, may request its removal or correction. 2) A third party detects the error, it is the obligation of the author to retract immediately and proceed to the public removal or correction.

• The opinions contained in the articles are attributable exclusively to the authors; therefore, the Institution is not responsible for what they may generate.